A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 27, Issue 1, Pages 106-114
Publisher
Springer Science and Business Media LLC
Online
2020-12-08
DOI
10.1038/s41591-020-1118-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay
- (2020) Veronika Chromikova et al. VACCINE
- Early Season Pediatric Influenza B/Victoria Virus Infections Associated with a Recently Emerged Virus Subclade — Louisiana, 2019
- (2020) Daniel Owusu et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface
- (2019) Sandhya Bangaru et al. CELL
- Antibodies to a Conserved Influenza Head Interface Epitope Protect by an IgG Subtype-Dependent Mechanism
- (2019) Akiko Watanabe et al. CELL
- Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
- (2019) Catherine Cohet et al. VACCINE
- Novel correlates of protection against pandemic H1N1 influenza A virus infection
- (2019) Sophia Ng et al. NATURE MEDICINE
- Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
- (2019) Meagan McMahon et al. Frontiers in Immunology
- Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018–2019 Season
- (2019) Brendan Flannery et al. JOURNAL OF INFECTIOUS DISEASES
- Broadly protective human antibodies that target the active site of influenza virus neuraminidase
- (2019) Daniel Stadlbauer et al. SCIENCE
- Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial
- (2019) David I Bernstein et al. LANCET INFECTIOUS DISEASES
- Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity
- (2019) Ramandeep K. Virk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice
- (2019) Carly M. Bliss et al. Molecular Therapy-Methods & Clinical Development
- Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts
- (2019) Raffael Nachbagauer et al. npj Vaccines
- Structural insights into the design of novel anti-influenza therapies
- (2018) Nicholas C. Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations
- (2018) Madhusudan Rajendran et al. PLoS One
- Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin
- (2018) Irina Isakova-Sivak et al. VIROLOGY
- Structural insights into the design of novel anti-influenza therapies
- (2018) Nicholas C. Wu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The influenza virus hemagglutinin head evolves faster than the stalk domain
- (2018) Ericka Kirkpatrick et al. Scientific Reports
- Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial
- (2017) Punnee Pitisuttithum et al. LANCET INFECTIOUS DISEASES
- Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
- (2017) Madhusudan Rajendran et al. mBio
- Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
- (2017) Henning Jacobsen et al. mBio
- A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
- (2017) Raffael Nachbagauer et al. npj Vaccines
- Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody
- (2017) Veronika Chromikova et al. PLoS One
- Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination
- (2016) Jiwon Lee et al. NATURE MEDICINE
- Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin
- (2016) Michael Doud et al. Viruses-Basel
- Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans
- (2016) Raffael Nachbagauer et al. mBio
- A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice
- (2016) Raffael Nachbagauer et al. npj Vaccines
- Advances in the development of influenza virus vaccines
- (2015) Florian Krammer et al. NATURE REVIEWS DRUG DISCOVERY
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
- (2015) A. Impagliazzo et al. SCIENCE
- Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine
- (2015) Larisa Rudenko et al. Human Vaccines & Immunotherapeutics
- A Live Attenuated Influenza A(H5N1) Vaccine Induces Long-Term Immunity in the Absence of a Primary Antibody Response
- (2014) Kawsar R. Talaat et al. JOURNAL OF INFECTIOUS DISEASES
- Induction of Broadly Reactive Anti-Hemagglutinin Stalk Antibodies by an H5N1 Vaccine in Humans
- (2014) R. Nachbagauer et al. JOURNAL OF VIROLOGY
- Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo
- (2014) David J DiLillo et al. NATURE MEDICINE
- Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
- (2014) A. H. Ellebedy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site
- (2013) M. Hong et al. JOURNAL OF VIROLOGY
- H3 Stalk-Based Chimeric Hemagglutinin Influenza Virus Constructs Protect Mice from H7N9 Challenge
- (2013) F. Krammer et al. JOURNAL OF VIROLOGY
- Hemagglutinin Stalk-Based Universal Vaccine Constructs Protect against Group 2 Influenza A Viruses
- (2013) I. Margine et al. JOURNAL OF VIROLOGY
- Chimeric Hemagglutinin Influenza Virus Vaccine Constructs Elicit Broadly Protective Stalk-Specific Antibodies
- (2013) F. Krammer et al. JOURNAL OF VIROLOGY
- Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization
- (2013) Boerries Brandenburg et al. PLoS One
- Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins
- (2013) N. S. Heaton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Localized Mucosal Response to Intranasal Live Attenuated Influenza Vaccine in Adults
- (2012) Maria Ines Barría et al. JOURNAL OF INFECTIOUS DISEASES
- Influenza Viruses Expressing Chimeric Hemagglutinins: Globular Head and Stalk Domains Derived from Different Subtypes
- (2012) R. Hai et al. JOURNAL OF VIROLOGY
- Cross-neutralization of influenza A viruses mediated by a single antibody loop
- (2012) Damian C. Ekiert et al. NATURE
- Highly Conserved Protective Epitopes on Influenza B Viruses
- (2012) C. Dreyfus et al. SCIENCE
- Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A Antibodies
- (2011) J. Sui et al. CLINICAL INFECTIOUS DISEASES
- A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins
- (2011) D. Corti et al. SCIENCE
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
- (2011) S. Khurana et al. Science Translational Medicine
- Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2)
- (2011) Irina Isakova-Sivak et al. VIROLOGY
- Immune Response to Influenza Vaccine in Children With Inflammatory Bowel Disease
- (2009) Ying Lu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
- (2009) Jianhua Sui et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Antibody Recognition of a Highly Conserved Influenza Virus Epitope
- (2009) D. C. Ekiert et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started